Logo image of UHS

UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis

USA - NYSE:UHS - US9139031002 - Common Stock

186.105 USD
-0.16 (-0.08%)
Last: 9/17/2025, 10:09:09 AM
Fundamental Rating

6

UHS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make UHS a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

UHS had positive earnings in the past year.
UHS had a positive operating cash flow in the past year.
Each year in the past 5 years UHS has been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of UHS (8.41%) is better than 92.08% of its industry peers.
Looking at the Return On Equity, with a value of 17.94%, UHS belongs to the top of the industry, outperforming 86.14% of the companies in the same industry.
UHS's Return On Invested Capital of 11.02% is amongst the best of the industry. UHS outperforms 84.16% of its industry peers.
UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.19%.
The last Return On Invested Capital (11.02%) for UHS is above the 3 year average (8.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.41%
ROE 17.94%
ROIC 11.02%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

UHS's Profit Margin of 7.66% is amongst the best of the industry. UHS outperforms 89.11% of its industry peers.
In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
UHS has a better Operating Margin (11.01%) than 82.18% of its industry peers.
In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
Industry RankSector Rank
OM 11.01%
PM (TTM) 7.66%
GM N/A
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
UHS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UHS has been reduced compared to 5 years ago.
Compared to 1 year ago, UHS has an improved debt to assets ratio.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 3.10 indicates that UHS is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.10, UHS is doing good in the industry, outperforming 62.38% of the companies in the same industry.
UHS has a debt to FCF ratio of 5.08. This is a neutral value as UHS would need 5.08 years to pay back of all of its debts.
UHS's Debt to FCF ratio of 5.08 is fine compared to the rest of the industry. UHS outperforms 68.32% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: UHS outperforms 55.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.08
Altman-Z 3.1
ROIC/WACC1.38
WACC7.96%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

UHS has a Current Ratio of 1.29. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of UHS (1.29) is comparable to the rest of the industry.
A Quick Ratio of 1.19 indicates that UHS should not have too much problems paying its short term obligations.
UHS's Quick ratio of 1.19 is in line compared to the rest of the industry. UHS outperforms 43.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.19
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.47%, which is quite impressive.
Measured over the past years, UHS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.74% on average per year.
The Revenue has grown by 9.61% in the past year. This is quite good.
UHS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)37.47%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%24.13%
Revenue 1Y (TTM)9.61%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%9.63%

3.2 Future

Based on estimates for the next years, UHS will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.65% on average per year.
Based on estimates for the next years, UHS will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y24.6%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
EPS Next 5Y11.65%
Revenue Next Year9.3%
Revenue Next 2Y7.09%
Revenue Next 3Y6.45%
Revenue Next 5Y4.7%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.89, the valuation of UHS can be described as very reasonable.
Based on the Price/Earnings ratio, UHS is valued cheaply inside the industry as 91.09% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of UHS to the average of the S&P500 Index (27.20), we can say UHS is valued rather cheaply.
The Price/Forward Earnings ratio is 8.43, which indicates a very decent valuation of UHS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 93.07% of the companies listed in the same industry.
UHS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.71.
Industry RankSector Rank
PE 9.89
Fwd PE 8.43
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

86.14% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
81.19% of the companies in the same industry are more expensive than UHS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.14
EV/EBITDA 6.77
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
UHS's earnings are expected to grow with 13.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)0.92
EPS Next 2Y15.2%
EPS Next 3Y13.49%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.42%, UHS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.43, UHS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, UHS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.42%

5.2 History

On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

4.19% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP4.19%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (9/17/2025, 10:09:09 AM)

186.105

-0.16 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners98.55%
Inst Owner Change-1.18%
Ins Owners4.77%
Ins Owner Change16.93%
Market Cap11.84B
Analysts69.23
Price Target222.55 (19.58%)
Short Float %4.5%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 0.42%
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP4.19%
Div Incr Years0
Div Non Decr Years4
Ex-Date09-02 2025-09-02 (0.2)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.89%
Min EPS beat(2)7.62%
Max EPS beat(2)10.15%
EPS beat(4)4
Avg EPS beat(4)8.74%
Min EPS beat(4)0.53%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)11.9%
EPS beat(12)12
Avg EPS beat(12)9.02%
EPS beat(16)13
Avg EPS beat(16)5.35%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-2.29%
Max Revenue beat(2)0.18%
Revenue beat(4)3
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)1.57%
Revenue beat(8)6
Avg Revenue beat(8)0.11%
Revenue beat(12)9
Avg Revenue beat(12)0.14%
Revenue beat(16)13
Avg Revenue beat(16)0.46%
PT rev (1m)-1.33%
PT rev (3m)-2.88%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)4.77%
EPS NY rev (1m)4.31%
EPS NY rev (3m)4.32%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE 9.89
Fwd PE 8.43
P/S 0.72
P/FCF 13.14
P/OCF 6.23
P/B 1.68
P/tB 3.88
EV/EBITDA 6.77
EPS(TTM)18.82
EY10.11%
EPS(NY)22.08
Fwd EY11.87%
FCF(TTM)14.17
FCFY7.61%
OCF(TTM)29.86
OCFY16.05%
SpS258.65
BVpS110.47
TBVpS47.96
PEG (NY)0.4
PEG (5Y)0.92
Profitability
Industry RankSector Rank
ROA 8.41%
ROE 17.94%
ROCE 14.3%
ROIC 11.02%
ROICexc 11.14%
ROICexgc 16.33%
OM 11.01%
PM (TTM) 7.66%
GM N/A
FCFM 5.48%
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexcg growth 3Y1.9%
ROICexcg growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.08
Debt/EBITDA 1.89
Cap/Depr 167.41%
Cap/Sales 6.07%
Interest Coverage 12.09
Cash Conversion 78.91%
Profit Quality 71.49%
Current Ratio 1.29
Quick Ratio 1.19
Altman-Z 3.1
F-Score9
WACC7.96%
ROIC/WACC1.38
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)37.47%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%24.13%
EPS Next Y24.6%
EPS Next 2Y15.2%
EPS Next 3Y13.49%
EPS Next 5Y11.65%
Revenue 1Y (TTM)9.61%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%9.63%
Revenue Next Year9.3%
Revenue Next 2Y7.09%
Revenue Next 3Y6.45%
Revenue Next 5Y4.7%
EBIT growth 1Y25.67%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year54.97%
EBIT Next 3Y19.45%
EBIT Next 5YN/A
FCF growth 1Y77.13%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y62.2%
OCF growth 3Y32.75%
OCF growth 5Y7.52%